Skinny Labels at the Supreme Court: Carving Out Room for Generics to Breathe
HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for...
Jeremiah Helm Quoted on Supreme Court’s Skinny Label Patent Infringement Decision in Hikma v. Amarin
Knobbe Martens partner Jeremiah Helm was quoted by Bloomberg Law, Law360, and MLex on the U.S. Supreme Court’s unanimous ruling in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., which...
Jeremiah Helm Shares Post-Argument Insights on Supreme Court “Skinny Label” Patent Infringement Case, Hikma v. Amarin
Following April 29 oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the closely watched Supreme Court case on whether a generic drug manufacturer can be held liable...
Subscribe for News and Updates